fbpx

Comment and Opinion

Wall Street Journal: ‘On the Iran Nuclear Deal: Yes, but …,’ by Richard Haass

[ssba]

The agreement to constrain Iran’s nuclear capacity, the Joint Comprehensive Plan of Action (JCPOA), which the U.S. Congress will vote on next month, places significant limits on Iran’s nuclear program for a decade or longer. At the same time, the accord allows Iran access to resources that will enhance its ability to carry out a worrisome agenda throughout much of the Middle East. In addition, the agreement in no way resolves the problems posed by Iran’s nuclear program. To the contrary, these problems could well grow as most of the restrictions on centrifuges and enriched uranium run out after 10 and 15 years respectively.

So what should Congress do? Just to be clear, it is not being asked to vote on whether the accord is good or bad but whether the U.S. would be better or worse off with it. Nor should the vote be based on hopes the agreement will bring about a more moderate Iran. This is possible, but so, too, is the opposite. We cannot know if Iran will be transformed, much less how or how much. The agreement is a transaction that should be judged on its merits.

It is a close call. The JCPOA like any pact is filled with compromises, some understandable, others questionable. Unfortunately, renegotiating the accord is not an option. The U.S. would quickly make itself rather than Iran the issue. International support for sanctions would erode.

Rejecting the agreement would make it likely that Iran would resume nuclear activity in one or more areas the agreement prohibits. That would bring closer a difficult and far-reaching decision on whether to use military force in a preventive strike. Rejecting the agreement would also reinforce questions around the world as to American political dysfunction. Reliability and predictability are essential attributes for a great power that must both reassure and deter.

On the other hand, simply voting in support of the agreement does nothing to address its shortcomings.

Read the article in full at the Wall Street Journal.